nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Phenylephrine—MAOA—bipolar disorder	0.0195	0.753	CrCbGaD
Salbutamol—ADRB1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00917	0.00941	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—DRD5—bipolar disorder	0.009	0.00924	CbGpPWpGaD
Salbutamol—ADRB2—Monoamine GPCRs—HTR2A—bipolar disorder	0.00897	0.0092	CbGpPWpGaD
Salbutamol—ADRB1—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.00818	0.0084	CbGpPWpGaD
Salbutamol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00779	0.008	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.0077	0.00791	CbGpPWpGaD
Salbutamol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00762	0.00782	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00754	0.00774	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—ADM—bipolar disorder	0.00665	0.00683	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—ADM—bipolar disorder	0.00651	0.00668	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—PDE4B—bipolar disorder	0.00648	0.00665	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—TSHB—bipolar disorder	0.00648	0.00665	CbGpPWpGaD
Salbutamol—Norepinephrine—DRD2—bipolar disorder	0.0064	0.247	CrCbGaD
Salbutamol—ADRB2—G alpha (s) signalling events—TSHB—bipolar disorder	0.00634	0.00651	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—PDE4B—bipolar disorder	0.00634	0.00651	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Other—DRD3—bipolar disorder	0.00629	0.00645	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Other—DRD4—bipolar disorder	0.0061	0.00627	CbGpPWpGaD
Salbutamol—CYP3A4—Estrogen metabolism—COMT—bipolar disorder	0.00589	0.00605	CbGpPWpGaD
Salbutamol—ADRB2—Arf6 trafficking events—INS—bipolar disorder	0.00537	0.00551	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—DRD1—bipolar disorder	0.00518	0.00532	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00512	0.00526	CbGpPWpGaD
Salbutamol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00512	0.00525	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—DRD1—bipolar disorder	0.00507	0.0052	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00501	0.00514	CbGpPWpGaD
Salbutamol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00501	0.00514	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00459	0.00471	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—ADCY2—bipolar disorder	0.00449	0.00461	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00439	0.0045	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00429	0.0044	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Other—HTR2A—bipolar disorder	0.00398	0.00409	CbGpPWpGaD
Salbutamol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00396	0.00406	CbGpPWpGaD
Salbutamol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00387	0.00398	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD5—bipolar disorder	0.00334	0.00343	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD5—bipolar disorder	0.00327	0.00335	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00309	0.00317	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00309	0.00317	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00302	0.0031	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00302	0.0031	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00299	0.00306	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00292	0.003	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00288	0.00296	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00288	0.00296	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00282	0.0029	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00282	0.0029	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00279	0.00287	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00273	0.0028	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00271	0.00278	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00266	0.00273	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00265	0.00272	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00256	0.00263	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—POMC—bipolar disorder	0.00254	0.00261	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00253	0.00259	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00252	0.00259	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.0025	0.00257	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—POMC—bipolar disorder	0.00248	0.00255	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00247	0.00254	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00247	0.00254	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00247	0.00254	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00246	0.00253	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00242	0.00248	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00242	0.00248	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—ADM—bipolar disorder	0.00241	0.00248	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00239	0.00246	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—ADM—bipolar disorder	0.00236	0.00242	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—TSHB—bipolar disorder	0.00235	0.00242	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—TACR1—bipolar disorder	0.00235	0.00242	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00234	0.0024	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00232	0.00238	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—TSHB—bipolar disorder	0.0023	0.00236	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—TACR1—bipolar disorder	0.0023	0.00236	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00227	0.00233	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00216	0.00222	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00212	0.00217	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DGKH—bipolar disorder	0.00206	0.00212	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DGKH—bipolar disorder	0.00202	0.00207	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR1A—bipolar disorder	0.00195	0.002	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—TAC1—bipolar disorder	0.00192	0.00197	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR1A—bipolar disorder	0.00191	0.00196	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD5—bipolar disorder	0.00189	0.00194	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD1—bipolar disorder	0.00188	0.00193	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2C—bipolar disorder	0.00188	0.00193	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—TAC1—bipolar disorder	0.00188	0.00193	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DGKH—bipolar disorder	0.00187	0.00192	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—RGS4—bipolar disorder	0.00185	0.0019	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD5—bipolar disorder	0.00185	0.0019	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2C—bipolar disorder	0.00184	0.00189	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD1—bipolar disorder	0.00184	0.00189	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DGKH—bipolar disorder	0.00183	0.00188	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD3—bipolar disorder	0.00182	0.00187	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—RGS4—bipolar disorder	0.00181	0.00186	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00181	0.00186	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD3—bipolar disorder	0.00178	0.00183	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00177	0.00182	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD4—bipolar disorder	0.00177	0.00182	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00173	0.00178	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD4—bipolar disorder	0.00173	0.00178	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD5—bipolar disorder	0.00171	0.00176	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—RGS4—bipolar disorder	0.00168	0.00173	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD5—bipolar disorder	0.00168	0.00172	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD2—bipolar disorder	0.00165	0.00169	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RGS4—bipolar disorder	0.00164	0.00169	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD2—bipolar disorder	0.00161	0.00165	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00152	0.00156	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00148	0.00152	CbGpPWpGaD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00145	0.00149	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00143	0.00147	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TRPC3—bipolar disorder	0.0014	0.00144	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—ADM—bipolar disorder	0.00136	0.0014	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—ADM—bipolar disorder	0.00133	0.00137	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TACR1—bipolar disorder	0.00133	0.00137	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00133	0.00137	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TSHB—bipolar disorder	0.00133	0.00137	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PDE4B—bipolar disorder	0.0013	0.00134	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TSHB—bipolar disorder	0.0013	0.00134	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TACR1—bipolar disorder	0.0013	0.00134	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TRPC3—bipolar disorder	0.0013	0.00133	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TRPC3—bipolar disorder	0.00127	0.0013	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—ADM—bipolar disorder	0.00124	0.00127	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—ADM—bipolar disorder	0.00121	0.00124	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00121	0.00124	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PDE4B—bipolar disorder	0.00121	0.00124	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TSHB—bipolar disorder	0.00121	0.00124	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TACR1—bipolar disorder	0.00121	0.00124	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKR1C4—bipolar disorder	0.0012	0.00123	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00118	0.00122	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PDE4B—bipolar disorder	0.00118	0.00121	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TSHB—bipolar disorder	0.00118	0.00121	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TACR1—bipolar disorder	0.00118	0.00121	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00118	0.00121	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKR1C4—bipolar disorder	0.00118	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—bipolar disorder	0.00115	0.00118	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—bipolar disorder	0.00113	0.00116	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DGKH—bipolar disorder	0.00111	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1A—bipolar disorder	0.0011	0.00113	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TAC1—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DGKH—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00108	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	0.00106	0.00109	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00106	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	0.00106	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	0.00104	0.00107	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	0.00104	0.00107	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	0.00103	0.00106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD5—bipolar disorder	0.00101	0.00104	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	0.00101	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	0.001	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	0.001	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RGS4—bipolar disorder	0.000993	0.00102	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD5—bipolar disorder	0.00099	0.00102	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	0.000984	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	0.000978	0.001	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	0.000978	0.001	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RGS4—bipolar disorder	0.000971	0.000997	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000968	0.000994	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	0.000965	0.000991	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	0.000965	0.000991	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	0.000963	0.000989	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000961	0.000987	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000955	0.00098	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	0.000944	0.000969	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	0.000944	0.000969	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000941	0.000966	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	0.000935	0.00096	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	0.000931	0.000956	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—POMC—bipolar disorder	0.000922	0.000946	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	0.00092	0.000945	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	0.000915	0.000939	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	0.000911	0.000935	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	0.000908	0.000932	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—POMC—bipolar disorder	0.000902	0.000926	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	0.000888	0.000912	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	0.000854	0.000877	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	0.000846	0.000868	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	0.000836	0.000858	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000828	0.00085	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	0.000827	0.000849	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	0.000767	0.000788	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	0.000751	0.000771	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADM—bipolar disorder	0.000732	0.000751	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADM—bipolar disorder	0.000716	0.000735	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TACR1—bipolar disorder	0.000713	0.000732	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TSHB—bipolar disorder	0.000713	0.000732	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	0.000713	0.000732	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	0.000698	0.000716	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TACR1—bipolar disorder	0.000698	0.000716	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TSHB—bipolar disorder	0.000698	0.000716	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000652	0.000669	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000638	0.000655	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000626	0.000642	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	0.000592	0.000608	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	0.00059	0.000606	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TAC1—bipolar disorder	0.000582	0.000597	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	0.000579	0.000595	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	0.000578	0.000593	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	0.00057	0.000585	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD1—bipolar disorder	0.00057	0.000585	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TAC1—bipolar disorder	0.000569	0.000584	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.00056	0.000574	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	0.000558	0.000573	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD1—bipolar disorder	0.000558	0.000573	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	0.000555	0.00057	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD3—bipolar disorder	0.000552	0.000567	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	0.00055	0.000565	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	0.000543	0.000557	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD3—bipolar disorder	0.00054	0.000555	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	0.000538	0.000552	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	0.000536	0.00055	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	0.000525	0.000538	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	0.000521	0.000535	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	0.000509	0.000523	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	0.000505	0.000518	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000503	0.000516	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	0.0005	0.000513	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	0.000494	0.000507	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	0.000492	0.000505	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	0.000489	0.000502	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000476	0.000488	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	0.000473	0.000486	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	0.000463	0.000475	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000461	0.000473	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	0.000452	0.000464	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	0.000442	0.000454	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—S100B—bipolar disorder	0.00044	0.000451	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—S100B—bipolar disorder	0.00043	0.000441	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NR1D1—bipolar disorder	0.000414	0.000425	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCAN—bipolar disorder	0.000396	0.000406	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	0.000388	0.000398	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC5A3—bipolar disorder	0.000388	0.000398	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	0.00038	0.00039	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	0.00035	0.000359	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	0.000342	0.000351	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	0.000282	0.000289	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CLOCK—bipolar disorder	0.00028	0.000288	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—bipolar disorder	0.000279	0.000287	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—INS—bipolar disorder	0.000278	0.000285	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	0.000276	0.000283	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—bipolar disorder	0.000273	0.000281	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPH2—bipolar disorder	0.000273	0.000281	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TSHB—bipolar disorder	0.000273	0.000281	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNB2—bipolar disorder	0.000273	0.000281	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—INS—bipolar disorder	0.000272	0.000279	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DPYD—bipolar disorder	0.000269	0.000276	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CACNA1C—bipolar disorder	0.00025	0.000257	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	0.000244	0.00025	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SNAP25—bipolar disorder	0.000218	0.000224	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADCY2—bipolar disorder	0.000193	0.000198	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—bipolar disorder	0.000166	0.00017	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOA—bipolar disorder	0.000164	0.000169	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—bipolar disorder	0.000134	0.000137	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—bipolar disorder	0.000107	0.00011	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INS—bipolar disorder	0.000106	0.000109	CbGpPWpGaD
